Pneumostem

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NamePneumostem
Drug Alias NameMesenchymal stem cell therapy: bronchopulmonary dysplasia and haemorrhagePneumostem
ClassificationCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsPersonality DisordersInfant, Premature, DiseasesBronchopulmonary Dysplasia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMedipost Co LtdSamsung Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesMedipost Co LtdSamsung Medical Center
Inactive CompaniesMedipost America Inc
Active IndicationsPersonality DisordersInfant, Premature, DiseasesBronchopulmonary Dysplasia +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A